HSCT characteristics
| HSCT characteristics (N = 16 patients, 10 HMIA and 6 IBD) | |
|---|---|
| Median age at HSCT (years) | 1.16 (0.3–12.0) |
| Donor | MRD: 4 (29%) |
| MUD: 6 (42%) | |
| MMUD: 4 (29%) (missing data 2) | |
| Conditioning | RIC: 7 (47%) |
| MAC: 8 (53%) (missing data 1) | |
| aGVHD | 8 (50%) |
| cGVHD | 0 (0%) |
| Rejection | 1 (6%) |
| Outcome | Alive at the last follow-up = 7 (44%) |
| | Dead = 9 (56%) |
| Median follow-up | 3.76 years |
| HSCT characteristics ( | |
|---|---|
| Median age at HSCT (years) | 1.16 (0.3–12.0) |
| Donor | MRD: 4 (29%) |
| MUD: 6 (42%) | |
| MMUD: 4 (29%) (missing data 2) | |
| Conditioning | RIC: 7 (47%) |
| MAC: 8 (53%) (missing data 1) | |
| aGVHD | 8 (50%) |
| cGVHD | 0 (0%) |
| Rejection | 1 (6%) |
| Outcome | Alive at the last follow-up = 7 (44%) |
| | Dead = 9 (56%) |
| Median follow-up | 3.76 years |
MRD, matched related donor; MUD, matched unrelated donor; MMUD, mismatched unrelated donor; RIC, reduced-intensity conditioning; MAC, myeloablative conditioning; aGVHD, acute graft-versus-host disease; cGVHD, chronic graft-versus-host disease.
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.